SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing significant market momentum driven by a strong quarterly earnings report that highlighted the expansion of its Matrix-M adjuvant technology into over 30 oncology and infectious disease fields. While community sentiment is divided between optimism over potential strategic partnerships and frustration regarding executive compensation, shares are rallying as traders speculate on the firm's role in the vaccine landscape and potential future buyouts.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense bullish momentum as investors re-rate the company from a cyclical manufacturer to a foundational player in the AI infrastructure supercycle, driven by persistent supply shortages and explosive demand for high-bandwidth memory. While the community is actively debating the sustainability of this parabolic move, much of the discourse focuses on supply constraints, long-term earnings potential, and the divergence between current valuations and the massive scaling of AI data centers.

Aventus Network

Aventus Network is currently trending as the community highlights its low market capitalization, Polkadot integration, and recent strategic advisory appointments in the UAE as potential catalysts for a breakout. Traders are actively debating its enterprise-grade utility, with many expressing interest in its long-term potential while closely monitoring trading volume for signs of a sustained move.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is currently trending as a high-conviction speculative play driven by a billion-dollar colocation contract with Cerebras Systems, positioning it as a key AI infrastructure proxy ahead of the Cerebras IPO. The community is heavily debating the company's growth-focused capital raising strategy versus potential dilution, while retail investors remain focused on the potential for institutional rerating as the company scales its modular data center capacity.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant market interest driven by ongoing momentum in its mRNA oncology platform and promising clinical data from its flu and combination vaccine programs, which are currently being presented at major industry events. The community remains focused on the company's efforts to expand beyond COVID-19, with active discussions surrounding potential clinical readouts, institutional accumulation, and the stock's position as a high-beta biotech play with strong short-interest dynamics.

NovaChargeX Coin (NCX) is an Ethereum-based ERC-20 token connected to NovaChargeX LLC, a clean-energy company developing patented hybrid regenerative power systems designed to deliver continuous, grid-independent electricity. The token serves as the on-chain entry point to the NovaChargeX ecosystem, linking blockchain participants to a real-world infrastructure project focused on supplying 24/7 power to AI data centers, industrial facilities, and other operations that cannot tolerate downtime. NCX is positioned in the real-world asset (RWA) and clean-energy infrastructure category. The parent company has been recognized by the World Future Awards 2025 for Best Hybrid Regenerative Clean Energy System and has received coverage from Al Arabiya English, SolarQuarter, and Reuters. The token contract is deployed on Ethereum mainnet, ownership has been renounced, and a third-party security audit has been completed.

NovaChargeX Coin

NovaChargeX is capturing investor attention by positioning itself at the intersection of clean energy infrastructure, blockchain utility, and real-world asset integration. Community members are actively discussing the project's patented technology and its potential to address growing AI-related power demands while remaining in an early development stage.

Sun Communities, Inc. provides real estate management services. The firm operates through the following segments: Manufactured Home Communities, Recreational Vehicle, and Marina. The Manufactured Home Communities segment owns, operates, and develops manufactured housing communities and is in the business of acquiring, operating, and developing ground up communities to provide housing solutions. The Recreational Vehicle segment focuses on the development of recreational vehicle resorts and is in the business of acquiring, operating and developing ground up resorts throughout the U.S. and in Ontario, Canada. The Marina segment operates marinas and is in the business of acquiring and operating marinas throughout the U.S. The company was founded in 1975 and is headquartered in Southfield, MI.

Sun Communities, Inc.

Sun Communities is trending as investors react to a tentative settlement regarding a lawsuit that alleged misleading governance and financial disclosures, while the community continues to confuse the REIT with the unrelated blockchain project Sui.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

Investors are actively debating the Fundrise Innovation Fund, with many highlighting its exposure to high-growth private companies like Anthropic, SpaceX, and OpenAI while others warn of significant premiums over Net Asset Value and ongoing insider share sales. Community sentiment is deeply polarized between those betting on long-term growth and potential IPO catalysts and skeptics concerned about price volatility and speculative valuation.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is trending as retail and institutional investors pile into the stock, driven by a narrative that its specialized MRAM memory technology is essential for the future of edge AI and space-hardened infrastructure. The community is actively discussing its potential for a massive short squeeze due to its low float and perceived sympathy with broader semiconductor and memory market momentum.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. (WYFI) is currently trending as a speculative data center infrastructure play, fueled by anticipation surrounding the upcoming Cerebras IPO and ongoing discussions regarding its capacity expansion at the NC-1 facility. While some community members remain wary of the stock's recent volatility and the CEO's communication style, others are focused on its potential as a key beneficiary of the broader AI compute demand cycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Elon Musk’s Neuralink is reportedly exploring the use of its brain implant device to translate thoughts into text, aiming to enable people with speech impairments to communicate.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-19/musk-s-neuralink-plans-speech-trial-nonmedical-brain-implant">reported</a> on Friday that Neuralink plans to launch a clinical trial in the U.S. in October for this purpose. The company also hopes to have its device in a healthy person by 2030, the report added.&nbsp;“We’re currently envisioning a world where in about 3 to 4 years, there will be someone who’s otherwise healthy who’s going to get a Neuralink,” the company’s president, DJ Seo, said at the Korea Foundation for Advanced Studies in Seoul earlier this week, as reported by Bloomberg. Seo added that the company aims to initiate a new clinical trial to read speech from the brain, for which the U.S. Food and Drug Administration has granted it an Investigational Device Exemption.The exemption allows the company to start testing an unapproved device. Currently, there are no commercially available implants that read speech from the brain, Bloomberg noted. Neuralink is also working toward potential treatments for blindness and Parkinson’s disease, though it has yet to receive approval for any of its devices for commercial use.On Stocktwits, retail sentiment for <a href="https://stocktwits.com/symbol/NEURALINK">Neuralink</a> was ‘extremely bullish’ amid ‘extremely high’ message volume.Earlier this month, Neuralink <a href="https://stocktwits.com/news-articles/markets/equity/elon-musk-s-neuralink-expands-human-trials-as-12-patients-clock-15-000-hours-on-brain-chip/chwjH1mRdtC">announced</a> that 12 people worldwide are now living with its N1 implant, collectively recording more than 15,000 hours of device use across 2,000 days. The N1 is designed for people with quadriplegia caused by spinal cord injuries or Amyotrophic Lateral Sclerosis (ALS). Implanted through a surgical robot, the device enables users to move a computer cursor and interact with digital or physical tools solely through thought.According to Bloomberg, the company plans to implant devices in 20,000 people per year by 2031.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/equity/markets/kalvista-pharmaceuticals-hereditary-angioedema-drug-approved-in-eu-switzerland/chD3BkIR3TW">KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Neuralink logo is displayed on a mobile phone with Neuralink in the background in this photo illustration in Brussels, Belgium, on March 9, 2025. (Photo by Jonathan Raa/NurPhoto via Getty Images)

Elon Musk’s Neuralink Reportedly Plans To Translate Thoughts Into Text With Brain Implant Device

According to a Bloomberg report on Friday, Neuralink plans to launch a clinical trial in the U.S. in October for this purpose.

Equity

According to a Bloomberg report on Friday, Neuralink plans to launch a clinical trial in the U.S. in October for this purpose.


Neuralink, the brain-computer interface company founded by Elon Musk, said that 12 people around the world are now living with its N1 implant, collectively recording more than 15,000 hours of device use across 2,000 days.The update marks an expansion from June, when the company’s partner, the Barrow Neurological Institute in Phoenix, Arizona, announced that seven people with severe paralysis had received the device.&nbsp;At the time, Neuralink highlighted patients using the implant to play video games, design 3D machine parts, control robotic arms and communicate after losing speech due to amyotrophic lateral sclerosis (ALS).The N1 is designed for people with quadriplegia caused by spinal cord injuries or ALS. Implanted through a surgical robot, the device&nbsp;enables users to move a computer cursor and interact with digital or physical tools solely through thought.Neuralink also said in July that it is preparing to test its brain implant in Britain, partnering with University College London Hospitals and Newcastle Hospitals. Patients with severe paralysis will be eligible to enroll.The company raised $650 million in June to support its clinical studies. It began human trials in 2024 after addressing safety concerns raised earlier by the U.S. Food and Drug Administration, which initially rejected its application in 2022.On Stocktwits, retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/NEURALINK">Neuralink</a> was ‘extremely bullish’ amid ‘low’ message volume.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Elon Musk’s Neuralink Expands Human Trials As 12 Patients Clock 15,000 Hours On Brain Chip

The company also said in July that it is preparing to launch trials in Britain with top hospitals, expanding eligibility to patients with severe paralysis.

OpenAI and co-founder Sam Altman are reportedly set to back a startup that would compete with Elon Musk’s Neuralink.According to a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/04484164-724e-4fc2-92a2-e2c13ea639bd?FTCamp&amp;#61;engage/">report</a> by the Financial Times, the company in question is Merge Labs. It is seeking funds at an $850 million valuation, with OpenAI’s ventures team expected to provide the bulk of the capital.&nbsp;While Altman will not be personally investing in the company, he will be one of the co-founders, the report stated. However, it added that he may not be involved in the new entity’s day-to-day operations.&nbsp;Insiders told the publication that Altman supports the investment. The report said that the OpenAI CEO plans to launch the project alongside Alex Bania, who runs World, a retina-scanning digital ID project, which Altman also backs.It noted that the new startup aims to build brain-computer interfaces, which would put it in direct competition against Musk’s Neuralink. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/OPENAI">OpenAI</a> was in ‘extremely bullish’ territory, while retail sentiment around Musk’s <a href="https://stocktwits.com/symbol/NEURALINK">Neuralink</a> was in the ‘extremely bearish’ zone.The two billionaires have already&nbsp;<a href="https://stocktwits.com/news-articles/equity/markets/sam-altman-fires-back-at-elon-musk-over-apples-chatgpt-favoritism-claims/chrDUplRd7g">been at odds</a> of late, with Musk claiming on Monday that Apple (AAP) was biased toward OpenAI, making it “impossible” for other AI apps like xAI’s Grok to move up in the App Store’s rankings.&nbsp;"Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in the App Store, which is an unequivocal antitrust violation," Musk wrote on X. "XAI will take immediate legal action." xAI's Grok app currently sits in fifth position on the Apple App Store's top free apps chart, four spots away from ChatGPT. Retail sentiment on Stocktwits around <a href="https://stocktwits.com/symbol/XAI">xAI</a> was in 'bullish' territory at the time of writing.The pair co-founded OpenAI, though Musk exited the board in 2018 following disputes with Altman. The split sparked a bitter rivalry between the two as they fight for leadership in AI.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-tells-goldman-ceo-david-solomon-to-focus-on-being-a-dj/chrx4DMRdJg">Trump Tells Goldman CEO David Solomon To ‘Focus On Being a DJ’ Over ‘Bad’ Tariff Predictions</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of 'OpenAI' is displayed on a mobile phone with the photographs of Elon Musk and Sam Altman in Ankara, Turkiye on March 14, 2024. (Photo by Muhammed Selim Korkutata/Anadolu via Getty Images)

Musk–Altman Battle Heats Up With OpenAI’s Reported $850M Bet On Neuralink Competitor

OpenAI’s ventures team is expected to contribute the bulk of the financing in Merge Labs’ $850 million valuation round, the Financial Times said.

NEURALINK
Neuralink Corp.

Latest NEURALINK News

NEURALINKNeuralink Corp.

Latest NEURALINK News

NEURALINK
Neuralink Corp.